US FDA approves Jazz Pharma’s Ziihera to treat adults with …
3 days ago · Jazz Pharmaceuticals plc announced the US Food and Drug Administration (FDA) accelerated approval of Ziihera (zanidatamab-hrii) 50mg/mL for injection for intravenous use …
Syngene embarks on evaluating the bioequivalence of an …
4 days ago · Syngene has embarked on evaluating bioequivalence of an injectable for type-2 diabetes and weight management. This was after a global pharma company was scouting for …
Azurity Pharma gets US FDA approval for Danziten tablets, the first …
Nov 16, 2024 · Azurity Pharmaceuticals announced that the US Food and Drug Administration (FDA) has approved Danziten, the first and only nilotinib with no mealtime restrictions …
Boehringer Ingelheim’s Cyltezo to treat multiple chronic …
May 3, 2024 · Boehringer Ingelheim’s Cyltezo to treat multiple chronic inflammatory diseases gets US FDA approval: Ridgefield, Connecticut Friday, May 3, 2024, 11:00 Hrs [IST]
Late-breaking data reinforce long-term benefits of Abbott's …
5 days ago · Abbott, a global healthcare leader, announced late-breaking data for the Amplatzer Amulet Left Atrial Appendage (LAA) Occluder to treat people with atrial fibrillation (AFib) who …
PTC Therapeutics’ gene therapy, Kebilidi to treat AADC deficiency ...
Nov 15, 2024 · PTC Therapeutics, Inc., a global biopharmaceutical company, announced the US Food and Drug Administration (FDA) accelerated approval of its gene therapy for the …
US FDA grants accelerated approval to Novartis’ Scemblix for adult ...
Oct 31, 2024 · Novartis announced that Scemblix (asciminib) was granted accelerated approval by the US Food and Drug Administration (FDA) for adult patients with newly diagnosed …
Takeda’s vedolizumab receives US FDA approval to treat …
Apr 20, 2024 · Takeda’s vedolizumab receives US FDA approval to treat moderately to severely active Crohn’s disease: Osaka, Japan Saturday, April 20, 2024, 16:00 Hrs [IST]
AstraZeneca completes acquisition of Fusion Pharma
Jun 6, 2024 · AstraZeneca completes acquisition of Fusion Pharma: Cambridge, UK Thursday, June 6, 2024, 10:00 Hrs [IST] AstraZeneca announced the successful completion of the …
AstraZeneca to acquire clinical-stage biopharma company, Fusion …
Mar 20, 2024 · AstraZeneca to acquire clinical-stage biopharma company, Fusion Pharma for $2 billion: Cambridge, UK Wednesday, March 20, 2024, 11:00 Hrs [IST] AstraZeneca has entered …